acromegaly
ACROMEGALY
Acromegaly is a chronic, slowly developing disease with progressive disfigurement and disability. An early diagnosis is difficult as most signs and symptoms are due to long-standing overproduction of growth hormone &/or insulin-like growth factor (IGF-I) causing metabolic, endocrine and morphological changes.
Surgical intervention is the first-line of treatment for almost all patients with acromegaly unless there are contraindications or the patient refuses to undergo the procedure.

Definition

  • Acromegaly is a chronic, slowly developing disease with progressive disfigurement and disability. An early diagnosis is difficult as most signs and symptoms are due to long-standing overproduction of growth hormone (GH) and/or insulin-like growth factor (IGF-I) causing metabolic, endocrine and morphological changes

Signs and Symptoms

Symptoms due to excess growth hormone (GH) and/or insulin-like growth factor (IGF-I):

  • Soft tissue swelling and extremities enlargement
  • Hyperhidrosis (excessive sweating)
  • Coarsening of facial features
  • Prognathism
  • Macroglossia
  • Arthritis
  • Gigantism
  • Increased incidence of obstructive sleep apnea
  • Increased incidence of diabetes mellitus (glucose intolerance)
  • Increased incidence of cardiovascular diseases [hypertension, coronary heart disease (CHD)]
  • Metabolic effects: Hyperphosphatemia, hypercalciuria, hypertriglyceridemia and low high-density lipoprotein-C (HDL-C)
  • Increased incidence of colonic polyps and adenocarcinoma of colon

Symptoms due to pressure caused by suprasellar extension of pituitary adenoma:

  • Visual field
  • Diplopia (secondary to cranial nerve palsy)
  • Headache
  • Loss of pituitary function resulting in lethargy, infertility and loss of libido

Etiology

  • Rarely, from ectopic pituitary tumor or ectopic production of growth hormone by other tumors like cancers of pancreas or lung
  • May also be caused by ectopic production of growth hormone releasing hormone (GHRH) by a tumor in the hypothalamus or tumors of the pancreas, kidney and lungs
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jun 2015
Long-term oral testosterone undecanoate significantly improved IPSS quality of life scores in a 1-year, randomised, multicentre, double-blind trial among aging hypogonadal men.
Rachel Soon, 01 Jun 2016

The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Rachel Soon, 01 Jun 2016

Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Prof. Cyrus Rustam Kumana, 07 Jul 2016

This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.